{"disease":{"id":"hepatorenal-syndrome","name":"Hepatorenal syndrome","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"glypressin","indication_name":"Hepatorenal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"glypressin","company_name":"Tanta University","drug_phase":"phase_1","molecular_target":"Vasopressin V1a receptor, Vasopressin V2 receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05387811","title":"International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project","phase":"","overall_status":"COMPLETED","enrollment_count":1456,"lead_sponsor_name":"Azienda Ospedaliera di Padova","has_results":false},{"nct_id":"NCT06095440","title":"A Retrospective Analysis of Outcomes in Patients with Hepatorenal Syndrome At Methodist Dallas Medical Center","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Methodist Health System","has_results":false},{"nct_id":"NCT02770716","title":"Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Mallinckrodt","has_results":true},{"nct_id":"NCT03530761","title":"Korean Cohort Study of AKI & HRS in Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":245,"lead_sponsor_name":"Soonchunhyang University Hospital","has_results":false},{"nct_id":"NCT02434445","title":"Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"The University of Hong Kong","has_results":false},{"nct_id":"NCT05434286","title":"Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury","phase":"","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"Post Graduate Institute of Medical Education and Research, Chandigarh","has_results":false},{"nct_id":"NCT04416282","title":"Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT03455322","title":"Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"National Hepatology & Tropical Medicine Research Institute","has_results":false},{"nct_id":"NCT07460908","title":"Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Lahore General Hospital","has_results":false},{"nct_id":"NCT06525623","title":"Initial Resuscitation for Acute Kidney Injury in Cirrhosis","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04460560","title":"Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University of Pennsylvania","has_results":true},{"nct_id":"NCT05309200","title":"A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Ocelot Bio, Inc","has_results":false},{"nct_id":"NCT06000748","title":"NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04048707","title":"Angiotensin 2 for Hepatorenal Syndrome","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of California, Los Angeles","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}